12 High Growth Large Cap Stocks to Buy Now
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Genmab A/S (GMAB)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,786,428 | $43,553,115 | +23% | 0.06% |
| 2. | Orbis Investment Management William B. Gray | 1,676,793 | $40,880,214 | 0.21% | |
| 3. | Citadel Investment Group Ken Griffin | 1,299,856 | $31,690,489 | +3% | 0% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 615,100 | $14,996,138 | +85% | 0.03% |
| 5. | Millennium Management Israel Englander | 564,832 | $13,770,604 | +49% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,614,510 | $497,165,998 | 0.19% | |
| 2. | 4,409,575 | $140,400,861 | 0% | |
| 3. | 4,057,922 | $129,650,575 | 0.02% | |
| 4. | 3,289,895 | $97,568,587 | 0.54% | |
| 5. | 2,369,331 | $75,439,498 | 0.01% |
News See All
Genmab A/S (NASDAQ:GMAB) Q3 2024 Earnings Call Transcript
Operator: Hello, and welcome to Genmab's Financial Results Conference Call for the First Nine Months of 2024. As a reminder, this conference call is being recorded.
12 Most Profitable Growth Stocks To Invest In
After the September inflation report, the market did feel a slight bit of panic but it seems to be fading away.
10 Stocks with Biggest Upside Potential According to Hedge Funds
The US equities saw a strong move after the September jobs report exceeded the economists’ estimates.
7 Best Revenue Growth Stocks to Buy According to Analysts
The Fed recently cut the funds rate by 50 basis points which has been considered a bold move by some analysts while others and most of the market have welcomed it with open arms.
10 Best Affordable Stocks Under $40 According to Short Sellers
Several traders tend to profit from stocks through appreciation. However, some do the opposite-- their idea is to profit from stocks when their value declines.
Genmab A/S (NASDAQ:GMAB) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to the Genmab First Half 2024 Financial Results Conference Call. As a reminder, this conference call is being recorded.
Genmab A/S (NASDAQ:GMAB) Q1 2024 Earnings Call Transcript
Genmab A/S reports earnings inline with expectations. Reported EPS is $0.16 EPS, expectations were $0.16.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Genmab A/S (NASDAQ:GMAB) Q4 2023 Earnings Call Transcript
Genmab A/S misses on earnings expectations. Reported EPS is $0.14 EPS, expectations were $0.35.
Billionaire Hedge Funds
